Sep 30, 2012

Amicus Therapeutics Q3 2012 Earnings Report

Total Revenue
$5.8M
Previous year: $5.8M
+0.0%
EPS
-$0.35
Previous year: -$0.28
+25.0%
Gross Profit
$2.12M
Previous year: $5.8M
-63.5%

Amicus Therapeutics

Amicus Therapeutics